Cleared Special

K231924 - EZ-IO Intraosseous Vascular Access System

K231924 is the FDA 510(k) clearance for EZ-IO Intraosseous Vascular Access System by Teleflex Medical. It is a Class 2 General Hospital device (product code FMI) cleared through the Special 510(k) pathway after a 25-day FDA review.

K231924 · Teleflex Medical · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
25d
Days
Class 2
Risk

K231924 is an FDA 510(k) clearance for the EZ-IO Intraosseous Vascular Access System. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Teleflex Medical (Morrisville, US). The FDA issued a Cleared decision on July 25, 2023 after a review of 25 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Teleflex Medical devices

Submission Details

510(k) Number K231924 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2023
Decision Date July 25, 2023
Days to Decision 25 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 129d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 235
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K231924.
Sterile syringes for single use with/without needle
K231729 · Wepon Medical Technology Co., Ltd. · Sep 2023
NovoFine® Plus
K231255 · Novo Nordisk, Inc. · Aug 2023
Altaviz Needle Kit II
K231261 · Altaviz, LLC · Jul 2023
Pen Needle
K230635 · Jiangsu Caina Medical Co.,Ltd · Jun 2023
Nipro SafeTouch Needle
K222852 · Nipro Medical Corporation · May 2023
Disposable Insulin Pen Needle
K222739 · Hantech Medical Device Co., Ltd. · Apr 2023